These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 37011101)
1. Risk factors for recurrences and visual impairment in patients with ocular toxoplasmosis: A systematic review and meta-analysis. Cifuentes-González C; Rojas-Carabali W; Pérez ÁO; Carvalho É; Valenzuela F; Miguel-Escuder L; Ormaechea MS; Heredia M; Baquero-Ospina P; Adan A; Curi A; Schlaen A; Urzua CA; Couto C; Arellanes L; de-la-Torre A PLoS One; 2023; 18(4):e0283845. PubMed ID: 37011101 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Bosch-Driessen LE; Berendschot TT; Ongkosuwito JV; Rothova A Ophthalmology; 2002 May; 109(5):869-78. PubMed ID: 11986090 [TBL] [Abstract][Full Text] [Related]
4. Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis. Zhang Y; Lin X; Lu F Acta Trop; 2018 Sep; 185():52-62. PubMed ID: 29704469 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of different antibiotic regimens in patients with ocular toxoplasmosis: systematic review and meta-analysis. Feliciano-Alfonso JE; Muñoz-Ortiz J; Marín-Noriega MA; Vargas-Villanueva A; Triviño-Blanco L; Carvajal-Saiz N; de-la-Torre A Syst Rev; 2021 Jul; 10(1):206. PubMed ID: 34275483 [TBL] [Abstract][Full Text] [Related]
11. Clinical manifestations and visual outcomes associated with ocular toxoplasmosis in a Brazilian population. Arruda S; Vieira BR; Garcia DM; Araújo M; Simões M; Moreto R; Rodrigues MW; Belfort R; Smith JR; Furtado JM Sci Rep; 2021 Feb; 11(1):3137. PubMed ID: 33542439 [TBL] [Abstract][Full Text] [Related]
12. Toxoplasma serotype is associated with development of ocular toxoplasmosis. Shobab L; Pleyer U; Johnsen J; Metzner S; James ER; Torun N; Fay MP; Liesenfeld O; Grigg ME J Infect Dis; 2013 Nov; 208(9):1520-8. PubMed ID: 23878321 [TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics, visual acuity outcomes, and factors associated with loss of vision among patients with active ocular toxoplasmosis: A retrospective study in a Thai tertiary center. Sittivarakul W; Treerutpun W; Tungsattayathitthan U PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012232. PubMed ID: 38843299 [TBL] [Abstract][Full Text] [Related]
14. Clinical pattern of ocular toxoplasmosis treated in a referral centre in Serbia. Kovačević-Pavićević D; Radosavljević A; Ilić A; Kovačević I; Djurković-Djaković O Eye (Lond); 2012 May; 26(5):723-8. PubMed ID: 22361847 [TBL] [Abstract][Full Text] [Related]
19. Assessment of ocular toxoplasmosis patients reported at a tertiary center in the northeast of Iran. Hosseini SM; Moghaddas E; Sharifi K; Dadgar Moghaddam M; Shamsian SA Int Ophthalmol; 2018 Dec; 38(6):2527-2533. PubMed ID: 29335806 [TBL] [Abstract][Full Text] [Related]
20. Recurrent ocular disease in postnatally acquired toxoplasmosis. Bosch-Driessen EH; Rothova A Am J Ophthalmol; 1999 Oct; 128(4):421-5. PubMed ID: 10577582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]